Skip to content

Starting HIV therapy improves some cardiovascular markers - but not all

Bone loss during HIV treatment most associated with protease inhibitors

FDA cautions that Kaletra should not be used by patients with heart rhythm problems or underlying heart conditions

Higher rates of breast enlargement in men in South Africa on ART

Vitamin D supplementation may help with tenofovir-related bone hormone deficiency

HIV treatment is not the cause of cryptogenic liver disease

Peripheral neuropathy: diagnosis and treatment

Peripheral neuropathy: diagnosis and treatment

Peripheral neuropathy in people with HIV in resource-limited settings

Peripheral neuropathy in people with HIV in resource-limited settings

Body-shape changes and lipid abnormalities common in HIV-positive children and young adults